Skip NavigationSkip to Content
Return Return to Search Results

Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma

  1. Author:
    Engels, E. A.
    Biggar, R. J.
    Marshall, V. A.
    Walters, M.
    Gamache, C. J.
    Whitby, D.
    Goedert, J. J.

  2. Author Address

    NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, DHHS, 6120 Execut Blvd,EPS 8010, Bethesda, MD 20892 USA NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, DHHS, Bethesda, MD 20892 USA NCI, Viral Epidemiol Sect, AIDS Vaccine Program, Frederick, MD 21701 USA Engels EA NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, DHHS, 6120 Execut Blvd,EPS 8010, Bethesda, MD 20892 USA
    1. Year: 2003
  2. Journal: Aids
    1. 17
    2. 12
    3. Pages: 1847-1851
  4. Type of Article: Article
  1. Abstract:

    Objective: To identify immunologic and virologic predictors of AIDS-associated Kaposi's sarcoma (KS). Design: Nested case- control analysis of KS risk in a cohort of 132 HIV-infected homosexual men in New York and Washington, DC, USA. Methods: For each KS case, we selected two HIV-infected controls, matched for CD4 cell count and Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8; KSHV) serostatus (enzyme immunoassay for antibody to KSHV protein K8.1). Cell-associated KSHV and Epstein-Barr virus (EBV) viral loads were measured with quantitative real-time PCR assays on samples collected 1 year (median) before KS diagnosis. Results: Thirty-one men developed AIDS-associated KS (incidence 3.1 per 100 person years). Among HIV-infected men, KS incidence was higher among those with K8.1 seropositivity (5.0 versus 1.4 per 100 person years; P = 0.004), low CD4 cell count [hazard ratio (HR), 1.49; 95% confidence interval (CI), 1.24-1.79 per 100 X 10(6) cells/l decline), or high HIV RNA level (HR, 3.96; 95% Cl, 2.19-7.16 per log(10)). In the case-control analysis, nine of 70 evaluated subjects had KSHV viremia, generally low level (median viral load 180 copies per 1 X 10(6) cells). KSHV viremia was associated with increased KS risk (unadjusted odds ratio, 9.1; 95% CI, 1.7-48; odds ratio, 11.7; 95% CI, 1.8-76 after adjustment for K8.1 serostatus, CD4 cell count, and HIV RNA). Among K8.1-seropositive subjects, KS incidence was tenfold higher in those with KSHV viremia (30.3 per 100 person years versus 3.4 per 100 person years in those without viremia). Also, EBV viral loads were higher in cases than in controls (P = 0.07). Conclusions: Among individuals with HIV- KSHV coinfection, KSHV viremia identifies a subgroup with extremely high risk for developing KS. (C) 2003 Lippincott Williams Wilkins.

    See More

  1. Keywords:

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel